- $801.14m
- $929.71m
- $139.91m
Brief: Avid Bioservices Reports Financial Results For Fourth Quarter And Full Fiscal Year
Avid Bioservices Inc reports results for the quarter ended in April - Earnings Summary
Avid Bioservices Inc expected to post earnings of 1 cent a share - Earnings Preview
Avid Bioservices Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: Avid Bioservices Announces Further Expansion Of Process Development Capacity For Mammalian Cell Business
Brief: Avid Bioservices Reports Financial Results For Third Quarter Ended January 31, 2022 And Recent Developments
Avid Bioservices Inc reports results for the quarter ended in January - Earnings Summary
Avid Bioservices Inc expected to post earnings of 4 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Altice USA, Dicerna Pharmaceuticals, Phillips 66
U.S. RESEARCH ROUNDUP-Altice USA, Dicerna Pharmaceuticals, Phillips 66
U.S. RESEARCH ROUNDUP-Elastic, Prometheus Biosciences, Stitch Fix
Avid Bioservices Inc reports results for the quarter ended in October - Earnings Summary
Avid Bioservices Inc expected to post earnings of 3 cents a share - Earnings Preview
Avid Bioservices Inc expected to post earnings of 3 cents a share - Earnings Preview
Brief: Avid Bioservices Set To Join S&P Smallcap 600
Brief: Avid Bioservices Inc Announces Expansion Into Viral Vector Development And Manufacturing Services For Cell And Gene Therapy
Avid Bioservices Inc reports results for the quarter ended in July - Earnings Summary
Brief: Avid Bioservices Q1 Earnings Per Share $0.10
Avid Bioservices Inc expected to post earnings of 4 cents a share - Earnings Preview